Chronic Lymphocytic Leukemia Fish Probe Kit

FDA classification

FDA Class 2 ·Chronic Lymphocytic Leukemia Fish Probe Kit

Ultrasound, Hyperthermia, Cancer Treatment

FDA classification

FDA Class 3 ·Ultrasound, Hyperthermia, Cancer Treatment

Antiserum, Blastomyces Dermatitidis, Other

FDA classification

FDA Class 2 ·Antiserum, Blastomyces Dermatitidis, Other

Early Growth Response Gene 1 (Egr1) Fish Probe Kit For Specimen Characterization

FDA classification

FDA Class 2 ·Early Growth Response Gene 1 (Egr1) Fish Probe Kit For Specimen Characterization

Early Growth Response 1 (Egr) Fish Probe Kit

FDA classification

FDA Class 2 ·Early Growth Response 1 (Egr) Fish Probe Kit

Test, Euglobulin Lysis

FDA classification

FDA Class 2 ·Test, Euglobulin Lysis

Radioimmunoassay, Lsd (125-I)

FDA classification

FDA Class 2 ·Radioimmunoassay, Lsd (125-I)

Free Radical Assay, Lsd

FDA classification

FDA Class 2 ·Free Radical Assay, Lsd

Bacteriophage And Controls, B. Anthracis Lysis

FDA classification

FDA Class 2 ·Bacteriophage And Controls, B. Anthracis Lysis

Drug-Eluting Sinus Stent

FDA classification

FDA Class 3 ·Drug-Eluting Sinus Stent

Catheters, Suction, Tracheobronchial

FDA classification

FDA Class 1 ·Catheters, Suction, Tracheobronchial

Algesimeter, Powered

FDA classification

FDA Class 2 ·Algesimeter, Powered

Detector And Alarm, Arrhythmia

FDA classification

FDA Class 2 ·Detector And Alarm, Arrhythmia

Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

FDA classification

FDA Class 2 ·Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

FDA classification

FDA Class 2 ·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

FDA classification

FDA Class 2 ·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

Simple Point-Of-Care Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Test

FDA classification

FDA Class 2 ·Simple Point-Of-Care Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Test

Simple In Vitro Diagnostic Device For The Detection Of Secreted Proteins From Bacillus Spp. In Human Clinical Samples

FDA classification

FDA Class 2 ·Simple In Vitro Diagnostic Device For The Detection Of Secreted Proteins From Bacillus Spp. In Human Clinical Samples